Onyx Pharmaceuticals announces delay in NDA filing for carfilzomib
Onyx Pharmaceuticals, Inc. today announced that it will delay its New Drug Application filing for carfilzomib based on a recent meeting with the Chemistry, Manufacturing and Controls review division of the US Food and Drug Administration.
Biotechnology company Genzyme Corp. said Tuesday it will face production delays on two key drugs because of a manufacturing issue at its Allston, Mass., facility.